PAVmed (PAVM) Profit After Tax Growth (5y) (2020 - 2025)
PAVmed (PAVM) Profit After Tax Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | PAVmed | 3.32 Mn | -9.85 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 32.08% |
| Sep 30, 2025 | -1.86% |
| Jun 30, 2025 | -17.18% |
| Mar 31, 2025 | 26.87% |
| Dec 31, 2024 | -18.96% |
| Jun 30, 2024 | -24.68% |
| Mar 31, 2024 | -32.65% |
| Dec 31, 2023 | -20.25% |
| Sep 30, 2023 | -46.29% |
| Jun 30, 2023 | -23.47% |
| Mar 31, 2023 | -44.71% |
| Dec 31, 2022 | -111.09% |
| Sep 30, 2022 | -38.48% |
| Jun 30, 2022 | -91.55% |
| Mar 31, 2022 | -31.63% |
| Dec 31, 2021 | -58.70% |
| Sep 30, 2021 | -47.94% |
| Jun 30, 2021 | -54.22% |
| Mar 31, 2021 | -70.73% |
| Dec 31, 2020 | -64.27% |